When was Cassini founded?

Cassini was founded in 2006 and raised its 1st funding round 10 years after it was founded.

Where is Cassini located?

Cassini is headquartered in The Hague, Netherlands.

Who is the current CEO of Cassini?

Jeroen Cammeraat and Joris Vogels s of Cassini.

How many employees does Cassini have?

As of Jul 31, 2026, the latest employee count at Cassini is 46.

Is Cassini a funded company?

Cassini is a funded company, having raised a total of $547K across 3 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Oct 2016.

When was the latest funding round of Cassini?

Cassini's latest funding was a $***** Series A round on Feb 26, 2018, with participation from 1 investor.

Where does Cassini rank among its competitors?

Cassini ranks 2nd amongst 45 active competitors, of which 8 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Big Vision, which secured $4.15M in May, 2024.

Who are the top competitors of Cassini?

Cassini's top competitors include Toku Eyes, Diagnostear and Konan Medical. Among them, Big Vision secured the most recent funding round in May, 2024.

Cassini - 2026 Company Profile, Team, Funding & Competitors

Cassini is a series A company based in The Hague (Netherlands), founded in 2006 by Jeroen Cammeraat and Joris Vogels. It operates as a Provider of corneal diagnostic solutions. Cassini has raised $547K in funding. The company has 45 active competitors, including 8 funded and 5 that have exited. Its top competitors include companies like Toku Eyes, Diagnostear and Konan Medical.

Company Details

Cassini Technologies offers corneal diagnostic solutions. The company offers a device that helps the physician to understand an individual's corneal properties in case of detecting Total Corneal Astigmatism measurements. Their device also provides corneal topography, mesopic, and photopic pupillometry along with colored photography for diagnostic purpose.

Website: www.cassini-technologies.com/
Phone Number: +31 **********
Part Of

Key Metrics

Founded Year

2006

Location

The Hague, Netherlands

Stage

Series A

Total Funding

$547K in 3 rounds

Latest Funding Round

Series A, Feb 26, 2018, $*****

Investors

IPF Partners & 1 more

Ranked

2^nd among 45 active competitors

Employee Count

46 as on Jul 31, 2026

Similar Companies

Toku Eyes & 60 more

View Cassini's full profile

Cassini has raised a total funding of $547K over 3 rounds. Its first funding round was on Oct 2016. Its latest funding round was a Series A round on Feb 26, 2018 for $*****. 1 investor participated in its latest round. Cassini has 2 institutional investors.

Here is the list of recent funding rounds of Cassini:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 26, 2018	8258964	Series A	8650681	3326510	3116682	9688596
Oct 2016	6123683	Series A	8105977	3794446	7392045	IPF Partners
Oct 2016	6709592	Conventional Debt	2711370	8800922	9112691	IPF Partners

Access funding benchmarks and valuations. Sign up today!

View details of Cassini's funding rounds and investors

The founders of Cassini are Jeroen Cammeraat and Joris Vogels.

Here are the details of Cassini's key team members:

Jeroen Cammeraat: Co-Founder & CEO of Cassini.
Contact Info: 1 email address
Joris Vogels: Co-Founder & CEO of Cassini.

View details of Cassini's Founder profiles and Board Members

Cassini's employee count trend

Cassini has 46 employees as of Jul 26. Here is Cassini's employee count trend over the years:

Uncover Cassini's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cassini include Toku Eyes, Diagnostear and Konan Medical. Here is the list of Top 10 competitors of Cassini, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Toku Eyes 2018, Auckland (New Zealand), Acquired	Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chronic kidney disease. The technology utilizes artificial intelligence to provide non-invasive, real-time assessments, potentially enabling earlier diagnosis and intervention. The company's products are subject to varying regulatory approvals depending on the region.	$10.5M	National Vision, Icehouse Ventures & 16 others	56/100
2nd	Cassini 2006, The Hague (Netherlands), Series A	Provider of corneal diagnostic solutions	$547K	IPF Partners, Innovation Industries	53/100
3rd	Diagnostear 2013, Tel Aviv (Israel), Public	Point-of-care diagnostic assay for Dry Eye Syndrome	$2.85M	Elcam Medical	43/100
4th	Konan Medical 1947, Orange (United States), Unfunded	Diagnostic devices for Ophthalmology	-	-	42/100
5th	Pr3vent 2017, San Francisco (United States), Series A	Provider of AI-based platform for ophthalmic conditions in newborns	$2.5M	Trousdale Ventures, Skyview Ventures & 1 others	42/100
6th	Octlight 2014, Lyngby (Denmark), Seed	Provider of non-invasive medical imaging light sources for eye diagnosis	$1.44M	Syddansk Innovation, EIC Fund & 4 others	41/100
7th	TearLab 2003, San Diego (United States), Acquired	Developer of diagnostic tests for detecting hyperosmolarity	-	CRG, Greybrook	40/100
8th	Shanggong Medical Letter 2014, Beijing (China), Series A	Provider of fundus screening and chronic disease management	$7.32M	DM Capital, Korea Investment Partners & 3 others	37/100
9th	BioLight 2005, Tel Aviv (Israel), Public	Diagnostics and therapeutics for ophthalmology	-	-	36/100
10th	Big Vision 2015, Suzhou (China), Series A	Provider of ophthalmology diagnosis and analysis systems	$8.52M	SND Ventures Group, Kunshan High-tech Venture Capital ... & 1 others	36/100